drugset / Trial / NCT02177461

Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension

NCT02177461

Phase 4 Completed 374 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

Study to assess the efficacy and tolerability of Telmisartan 40-80 mg once daily compared with enalapril 10-20 mg once daily in elderly patients with arterial hypertension.

Timeline

Start
2000-04
Primary completion
2002-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enalapril Other / unclassified 10 mg
Comparator Enalapril Other / unclassified 20 mg
Subject Telmisartan Other / unclassified 40 mg
Subject Telmisartan Other / unclassified 80 mg
Background Clonidine Other / unclassified

Indications